SLC2A1 and epilepsy: Five patients with epilepsy had not been treated with ASMs before KD start as seizure onset appeared simultaneously with investigations that revealed a neurometabolic disorder in which KD is recommended (four patients with PDHC deficiency and one patient with Glut1 DS).